DoNotAge Conference 2026 featured Søren Wilton Kudahl-Laursen of Aarhus University in a session focused on spermidine and age-related muscle stem-cell biology.
What the conference highlights establish
The official DoNotAge Conference 2026 highlights connect Kudahl-Laursen’s contribution with spermidine and muscle stem-cell proliferation. The topic sits within a wider ageing-research question: how changes in regenerative capacity contribute to declining skeletal-muscle function with age.
The conference material should be read as conference-stage evidence unless a specific paper, abstract or dataset is linked to an individual numerical claim. It does not by itself establish an effective human dose, a clinical treatment effect or a benefit from a particular commercial supplement.
Why muscle stem cells matter in ageing research
Skeletal-muscle repair depends in part on resident stem cells that can activate and proliferate in response to injury and physiological demand. Age-related changes in that regenerative system are one reason muscle ageing is studied as more than a simple loss of muscle mass.
Spermidine is a naturally occurring polyamine studied across several areas of ageing biology. The conference contribution places it in the narrower context of muscle stem-cell function and regenerative capacity.
What this does not prove
The conference presentation does not prove that taking a spermidine supplement preserves muscle mass, prevents sarcopenia or extends human lifespan. Those are separate clinical questions requiring appropriately designed human studies.
For the broader evidence base across human dosing, safety, cognition, immune ageing and biomarkers, see our Spermidine Research Data Center. If you are evaluating the standalone formula, see our DoNotAge Spermidine review, where product quality is graded separately from clinical efficacy.
Sources
Official DoNotAge Conference 2026 highlights
Return to the DoNotAge Conference 2026 hub.
Linked entities and research
DoNotAge Conference 2026
DoNotAge Conference 2026 was held in London on September 26–27, 2026. The official highlights archive presents 12 2026 conversations spanning human trials, DNA repair, inflammation, muscle and exercise, replication and research funding, plus a 2025 conference recap.
Can Spermidine Support Muscle Regeneration as We Age?
The conference highlighted two ongoing human studies using Pure Spermidine: a placebo-controlled muscle-recovery study in older adults, and a separate study in people with coronary artery disease. The summary describes study plans and measurements; it does not establish a completed clinical benefit.
Søren Wilton Kudahl-Laursen
DoNotAge Conference 2026 speaker. The official conference archive describes an ongoing older-adult muscle-regeneration study comparing DoNotAge Pure Spermidine with placebo; DoNotAge support is listed as research ingredients and matching placebo.